Empagliflozin Eases Functional Tricuspid Regurgitation Without Altering Right Ventricular Volumes
In the randomized PROVE trial, empagliflozin significantly reduced functional tricuspid regurgitation severity in heart failure patients with preserved ejection fraction ...


